Neuroprotective effects of VCP modulators in mouse models of glaucoma. - Wikidata - awgldk - TriplyDB

Neuroprotective effects of VCP modulators in mouse models of glaucoma.

Neuroprotective effects of VCP modulators in mouse models of glaucoma.

http://www.wikidata.org/entity/Q37096830

about

KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress.Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis.ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson's Disease.Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseases.Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma.Neuoroprotective efficacies by KUS121, a VCP modulator, on animal models of retinal degeneration.Glaucoma pathogenesis and neurotrophins: Focus on the Molecular and Genetic basis for Therapeutic prospects.KUS121, an ATP regulator, mitigates chorioretinal pathologies in animal models of age-related macular degeneration.Branched chain amino acids attenuate major pathologies in mouse models of retinal degeneration and glaucoma.

P2860

Q37710907-F087CE07-789F-4EF2-A159-04AB2C96FDED Q39167264-5EBB79D3-1FCF-4855-A0DF-E34035176452 Q41348875-1A18AE14-4A4C-4F61-BBBA-84E134355AD7 Q41667375-675AF19D-7245-4994-95DE-8309CA2DD542 Q41882390-E962AA4B-F0C6-4E84-A61E-75604349FEB8 Q41976417-C8BE9284-AFA6-49C0-B308-4A984D88925A Q52314492-CE27B1D3-31AE-4BA9-9280-CD02FED42D3A Q55003687-B3AB2B32-A3C5-47C7-955B-6ACD520F1415 Q55402017-96558187-EE41-4D43-ADD0-31C60DD1FD50

P2860

Neuroprotective effects of VCP modulators in mouse models of glaucoma.

http://www.wikidata.org/entity/Q37096830

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neuroprotective effects of VCP modulators in mouse models of glaucoma.

@en

Neuroprotective effects of VCP modulators in mouse models of glaucoma.

@nl

type

label

Neuroprotective effects of VCP modulators in mouse models of glaucoma.

@en

Neuroprotective effects of VCP modulators in mouse models of glaucoma.

@nl

prefLabel

Neuroprotective effects of VCP modulators in mouse models of glaucoma.

@en

Neuroprotective effects of VCP modulators in mouse models of glaucoma.

@nl

P1433

Q37096830-CFF860A1-13EC-4F16-A74A-86FB143DD0A7

P1476

Q37096830-630EB057-E4BC-46CA-BB37-11E493934D1D

P2093

Q37096830-03AD5F4E-C9C4-4C10-8CF2-E847275D11F2

Q37096830-1063A190-3121-4F6E-8CC4-873F6962F254

Q37096830-91E4EE48-9880-472A-9BEA-32C12FC00F8F

Q37096830-A1EA4CDD-5B50-433F-81FA-7872E3299CD0

Q37096830-A5AEDCFB-994E-4661-82DE-0155F1C03904

Q37096830-C01E6354-3FA4-4A17-BC5E-48891E7AB89E

Q37096830-D033AD40-9C83-4F32-A052-1A9FB49F1C26

Q37096830-EA7E874B-F8C5-40BF-A02B-BA9DBB5B9965

Q37096830-F4F11536-01E9-4C93-A901-8785A956C27F

P2860

Q37096830-08A5C609-D53A-4DA2-BDF7-E51DA995C90E

Q37096830-0ABC159C-6B00-4DF4-8472-9ADEDC5B3D20

Q37096830-1D166E2D-7417-40D7-88B9-4DF967391AE8

Q37096830-1ECCC3F0-8C7D-48C2-BA37-B9F20F679890

Q37096830-2D2EB3A7-0C6B-4A2B-9D24-BF9EC3672C93

Q37096830-2D70912D-FCA9-477D-87EB-868F3E6B00A1

Q37096830-2EAAE47F-DD9B-452D-8235-6D7793478037

Q37096830-36D09863-22BA-441D-8C1E-9386F9DB3CA9

Q37096830-3A2ACC86-0CF6-470C-931E-BB208D19D91A

Q37096830-4086DBEA-6173-49D8-9DD5-528EDD279E86

P304

Q37096830-5F40CB55-A4F7-40FD-8800-BC28A866E612

P31

Q37096830-2A4F2C7E-98FF-4914-96F3-9CADB156EC06

P356

Q37096830-A6E5E3B3-5D24-4D11-83DF-CA0C0BC0C825

P433

Q37096830-B7F25908-BE18-4EB9-8E8A-DA37030E1B88

P478

Q37096830-60EDC055-5253-4FC6-B701-A74AD6B08B39

P50

Q37096830-00D894A5-8C15-4BD5-A41A-BFBCA2C6D921

Q37096830-7545135E-9237-46CE-B250-B5C282B0496E

P577

Q37096830-763D0887-486A-4049-9D08-FDBA384FDC5C

P698

Q37096830-B37CD06D-2C53-4DB9-9A8E-04D0EDAD0FF0

P932

Q37096830-7A0EBC2F-6383-4566-9F45-6480009B5B20

P356

J.HELIYON.2016.E00096

P1433

P1476

Neuroprotective effects of VCP modulators in mouse models of glaucoma.

@en

P2093

Akira Kakizuka

http://www.w3.org/2001/XMLSchema#string

Hanako Ohashi Ikeda

http://www.w3.org/2001/XMLSchema#string

Masaki Nakano

http://www.w3.org/2001/XMLSchema#string

Noriko Nakano

http://www.w3.org/2001/XMLSchema#string

Tatsuaki Tsuruyama

http://www.w3.org/2001/XMLSchema#string

Tomohiro Fuchigami

http://www.w3.org/2001/XMLSchema#string

Tomoko Hasegawa

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Shudo

http://www.w3.org/2001/XMLSchema#string

Yuki Muraoka

http://www.w3.org/2001/XMLSchema#string

P2860

Exome sequencing reveals VCP mutations as a cause of familial ALS

The number of people with glaucoma worldwide in 2010 and 2020

A molecular mechanism for glaucoma: endoplasmic reticulum stress and the unfolded protein response

Mechanisms of caspase activation

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo

CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum

Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP

Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein

Involvement of ER stress in retinal cell death

P304

e00096

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HELIYON.2016.E00096

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Nagahisa Yoshimura

P577

2016-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27441270

http://www.w3.org/2001/XMLSchema#string

P932

4946081

http://www.w3.org/2001/XMLSchema#string